date,title,source
Oct-17-18,2 Big Pharmas Pleased With J&J's Third-Quarter Earnings Report,Motley Fool
Oct-17-18,"They tackled chronic cough. Now with $54.5 million, this duo is targeting Alzheimer's and more",American City Business Journals
Oct-17-18,Merck Announces Appointment of Jim Scholefield as Chief Information and Digital Officer,Business Wire
Oct-17-18,5 Blue Chip Drug Stocks Poised for Long-Term Gains,Investopedia
Oct-18-18,Jim Scholefield Leaves Nike for Top Tech and Digital Job at Merck,The Wall Street Journal
Oct-18-18,"Merck, Pfizer combo treatment meets main goals of kidney cancer trial",Reuters
Oct-18-18,"Merck, Pfizer combo treatment meets main goals of kidney cancer trial",Reuters
Oct-19-18,Merck (MRK) Gains As Market Dips: What You Should Know,Zacks
Oct-19-18,2 Dow Safety Stock for Volatile Market: Portfolio Manager,Investopedia
Oct-19-18,"Top Stock Reports for UPS, Merck & BHP Billiton",Zacks
Oct-19-18,Why Merck's Latest Success Means Trouble for Exelixis Inc.,Motley Fool
Oct-19-18,"Today's Research Reports on Trending Tickers: Merck & Co., and Bristol-Myers Squibb",ACCESSWIRE
Oct-22-18,Why Aduro Biotech Crashed 29.5% Today,Motley Fool
Oct-22-18,"Why Tesaro, Inc. Is Tanking Today",Motley Fool
Oct-22-18,Here's Why Clovis Oncology Dropped as Much as 21.2% Today,Motley Fool
Oct-22-18,Here's Why ImmunoGen Fell Today,Motley Fool
Oct-22-18,Bristol-Myers Squibb stock drops 6% after FDA delays approval deadline for cancer drug,MarketWatch
Oct-22-18,"Mercks KEYTRUDA (pembrolizumab) Significantly Improved Overall Survival Compared to Standard of Care, as Monotherapy and in Combination with Chemotherapy, as First-Line Treatment for Patients with Recurrent or Metastatic Head and Neck Cancer",Business Wire
Oct-22-18,Merck (MRK) to Report Q3 Earnings: What's in the Cards?,Zacks
Oct-22-18,Strong Earnings Enough Reason to Stay Long JNJ Stock,InvestorPlace
Oct-24-18,Merck's Q3 Earnings Preview,Benzinga
Oct-25-18,Dow Closes 400 Points Higher as Wall Street Rebounds on Earnings,TheStreet.com
Oct-25-18,Edited Transcript of MRK earnings conference call or presentation 25-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-25-18,"Merck & Co., Inc. -- Moody's: Merck's shareholder payouts credit negative",Moody's
Oct-25-18,"Pharma Giants Merck, Bristol Diverge On Earnings Beat As Sales Lag",Investor's Business Daily
Oct-25-18,Merck & Co Inc (MRK) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-25-18,Merck and Bristol-Myers Squibb Are Seeing Rising Sales of Their Cancer Drugs,Barrons.com
Oct-25-18,"Merck (MRK) Beats on Q3 Earnings, Lags Sales, Ups EPS View",Zacks
Oct-25-18,Former P&Ger joins Merck C-suite,American City Business Journals
Oct-25-18,"Merck, Bristol-Myers profits rise on cancer drug sales",Reuters
Oct-25-18,"Merck, Bristol-Myers profits rise on cancer drug sales",Reuters
Oct-25-18,Merck posts global sales of $11B in third quarter,Associated Press
Oct-25-18,"Merck&Co Earnings beat, Revenue misses In Q3",Investing.com
Oct-25-18,J&J Intends to Buy Residual Stake in Japanese Skincare Firm,Zacks
Oct-25-18,Merck says to retain animal health business as part of company,Reuters
Oct-25-18,3 Beaten-Down Biotech Stocks: Can They Bounce Back?,Motley Fool
Oct-25-18,"Cancer drug Keytruda powers Merck's profit beat, forecast raise",Reuters
Oct-25-18,Merck (MRK) Q3 Earnings Surpass Estimates,Zacks
Oct-25-18,[$$] Merck's 3Q Profit Misses Expectations,The Wall Street Journal
Oct-25-18,Drugmaker Merck beats profit estimate on Keytruda strength,Reuters
Oct-25-18,[$$] Bristol-Myers Squibb Raises Full-Year Profit Forecast,The Wall Street Journal
Oct-25-18,Bristol-Myers profit rises on better-than-expected cancer drug sales,Reuters
Oct-25-18,"Merck raises quarterly dividend by 15% to 55 cents a share, unveils $10 billion buyback",MarketWatch
Oct-25-18,Merck reports third-quarter profit vs year-ago loss,Reuters
Oct-25-18,Merck Announces Increased Fourth-Quarter Dividend and $10 Billion Share Repurchase Authorization,Business Wire
Oct-25-18,Merck Announces Third-Quarter 2018 Financial Results,Business Wire
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-26-18,"Company News For Oct 26, 2018",Zacks
Oct-26-18,Edited Transcript of MRK earnings conference call or presentation 25-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-29-18,Merck (MRK) Gains As Market Dips: What You Should Know,Zacks
Oct-29-18,Biogen And Eisai May Be At Odds In Alzheimer's  So What Now?,Investor's Business Daily
Oct-31-18,The Pharmaceuticals Industry Stock Outlook: A Steady Path Ahead,Zacks
Oct-31-18,"The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut",Benzinga
Nov-01-18,"Novo Nordisk (NVO) Reports In-Line Q3 Earnings, Beats Sales",Zacks
Nov-01-18,"Zoetis (ZTS) Beats on Q3 Earnings & Sales, Updates '18 View",Zacks
Nov-01-18,Does Merck & Co Incs (NYSE:MRK) CEO Pay Reflect Performance?,Simply Wall St.
Nov-01-18,Merck CEO on US healthcare system and drug pricing,CNBC Videos
Nov-01-18,"Big pharma leases almost 500,000 square feet for new research center",American City Business Journals
Nov-01-18,Edited Transcript of MRK earnings conference call or presentation 25-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,3 Pharma Stocks to Make a Portfolio Feel Better,Investopedia
Nov-02-18,"AMAG Posts Wider-Than-Expected Q3 Loss, Beats on Revenues",Zacks
Nov-02-18,"The Zacks Analyst Blog Highlights: Amazon, Facebook, Mastercard and Merck",Zacks
Nov-02-18,Dow Recovers More Than 900 Points in 3 Days: 5 Top Picks,Zacks
Nov-02-18,"New Research Coverage Highlights Landstar System, CMS Energy, MoSys, Pennsylvania Real Estate Investment Trust, Procter & Gamble, and Merck & Co.  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Nov-05-18,Epizyme (EPZM) Reports Narrower-Than-Expected Loss in Q3,Zacks
Nov-05-18,"ImmunoGen (IMGN) Beats on Earnings in Q3, Lowers Guidance",Zacks
Nov-06-18,5 Companies Hit 52-Week Highs,GuruFocus.com
Nov-06-18,Democrats Hold Edge in House Battle: 5 Great Picks,Zacks
Nov-07-18,"Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View",Zacks
Nov-07-18,"'We have a lot of things in common'  Trump wants to work with Democrats on infrastructure, drugs",CNBC
Nov-07-18,Early Phase 1 Data from Mercks Oncology Pipeline for Investigational Anti-LAG-3 Therapy (MK-4280) and Anti-TIGIT Therapy (MK-7684) to Be Presented at SITCs 33rd Annual Meeting,Business Wire
Nov-08-18,Merck (MRK) Gains As Market Dips: What You Should Know,Zacks
Nov-08-18,Endo Plans For Cellulite Drug In 2020  Here's Why Investors Balked,Investor's Business Daily
Nov-08-18,AstraZeneca Breaks Out As CEO Predicts 'Sustained Growth' Streak,Investor's Business Daily
Nov-08-18,Jeff Auxier Comments on Biogen,GuruFocus.com
Nov-08-18,"Horizon Pharma (HZNP) Q3 Earnings & Sales Beat, Shares Rise",Zacks
Nov-08-18,Merck and Johnson & Johnson Shares Show Big Buying,Investopedia
Nov-08-18,Democrats Hold Edge in House Battle: 5 Great Picks (Revised),Zacks
Nov-08-18,Endo stock rises 6% after Q3 beats and upbeat 2018 guidance,MarketWatch
Nov-12-18,5 Stocks to Sell After the Midterm Election,InvestorPlace
Nov-12-18,October's biggest Losers And Most Surprising Winners,Benzinga
Nov-12-18,Merck's (MRK) Keytruda Gets FDA Approval for Liver Cancer,Zacks
Nov-13-18,Daniel Loeb Purchases 7 Stocks in 3rd Quarter,GuruFocus.com
Nov-13-18,Merck Begins Rolling Submission of Licensure Application for V920 (rVSVG-ZEBOV-GP) to U.S. Food and Drug Administration,Business Wire
Nov-13-18,"Bayer (BAYRY) Beats on Q3 Earnings, Revenue Estimates",Zacks
Nov-14-18,Merck (MRK) Stock Moves -0.7%: What You Should Know,Zacks
Nov-14-18,AbbVie's HCV Drug Mavyret Succeeds in Label Expansion Study,Zacks
Nov-14-18,Merck Starts Rolling BLA Submission for Ebola Vaccine V920,Zacks
Nov-14-18,Can These 2 Battered Biotech Stocks Recover?,Motley Fool
Nov-14-18,"The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut",Benzinga
Nov-14-18,Merck drug Keytruda succeeds in late-stage esophageal cancer trial,Reuters
Nov-15-18,Mallinckrodt Gets FDA Committee Vote for Abuse-Deterrent Drug,Zacks
Nov-15-18,Merck's Keytruda Improves Survival in Esophageal Cancer Study,Zacks
Nov-16-18,"Pharma Stock Roundup: FDA Updates on MRK, AZN's Cancer Drugs, Bayer's Q3 Earnings",Zacks
Nov-16-18,A Look At Merck & Co Incs (NYSE:MRK) Exceptional Fundamentals,Simply Wall St.
Nov-19-18,"AstraZeneca's Imfinzi Fails in Lung Cancer Study, Stock Down",Zacks
Nov-19-18,"Drug Pricing Resurfaces, Pfizer to Raise Cost of 41 Drugs",Zacks
Nov-19-18,"Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer",PR Newswire
Nov-21-18,Merck (MRK) Gains But Lags Market: What You Should Know,Zacks
Nov-21-18,Pfizer Stock Has Multiple Positive Catalysts,InvestorPlace
Nov-21-18,Not business as usual: Rockville biotechs new CEO wants to turn things around,American City Business Journals
Nov-21-18,October's Biggest Losers And Most Surprising Winners,Benzinga
Nov-21-18,"Mylan Recalls Valsartan Lots, Gets FDA Warning for Facility",Zacks
Nov-21-18,IntelGenx's NDA Resubmission for Rizaport Gets FDA Acceptance,Zacks
Nov-21-18,FDA Accepts Allergan's (AGN) sNDA for Anti-Infective Avycaz,Zacks
Nov-21-18,Shire-Takeda Deal Gets Phase I Conditional European Approval,Zacks
Nov-21-18,TESARO Shares Rally on Rumors of Potential Acquisition Offer,Zacks
Nov-21-18,"Amid sell-off, top analysts are getting bullish these 5 defensive stocks including Merck",CNBC
Nov-21-18,Can Deal Interest Help Tesaro Recover?,Motley Fool
Nov-21-18,Today's Research Reports on Trending Tickers: Johnson & Johnson and Merck & Co.,ACCESSWIRE
Nov-23-18,Bayer Hurts from Generic Competition & Pipeline Setbacks,Zacks
Nov-26-18,AMAG's Label Expansion of Lead Products Raises Share Price,Zacks
Nov-26-18,"Bayer looks at options for consumer brands, animal health - sources",Reuters
Nov-26-18,"Bayer discusses sale of some consumer brands, future of animal health-sources",Reuters
Nov-26-18,Glaxo Inks Marketing Deal for Anaemia Candidate in Japan,Zacks
Nov-27-18,Accenture Brings Open Partner Ecosystem for Drug Discovery,Zacks
Nov-27-18,Merck (MRK) Outpaces Stock Market Gains: What You Should Know,Zacks
Nov-27-18,"Alnylam, Vir Begin Phase I/II Study on Hepatitis B Candidate",Zacks
Nov-27-18,Bristol-Myers' Opdivo-Yervoy Combo Fails in Lung Cancer Trial,Zacks
Nov-27-18,This Pharma Giant Is Still Consolidating Despite Lung Cancer Flop,Investor's Business Daily
Nov-27-18,Astrazeneca's Fasenra Gets Orphan Drug for Autoimmune Disease,Zacks
Nov-28-18,Merck raised prices five drugs including Keytruda in November,Reuters
Nov-28-18,Pfizer's Epilepsy Drug Lyrica Gets Pediatric Exclusivity,Zacks
Nov-28-18,"European Commission Approves Mercks DELSTRIGO (doravirine / lamivudine / tenofovir disoproxil fumarate), a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and PIFELTRO (doravirine), an NNRTI, Both for the Treatment of HIV-1 in Appropriate Patients",Business Wire
Nov-29-18,[$$] Another Bad Deal for Bayer,The Wall Street Journal
Nov-29-18,Merck (MRK) Receives Approval for 2 HIV Medicines in EU,Zacks
Nov-29-18,Moderna IPO On Path To Be Largest Offering Of Venture-Backed Biotech,Investor's Business Daily
Nov-29-18,"Bayer to sell businesses, cut jobs after Monsanto deal",Reuters
Nov-29-18,"Bayer to sell businesses, cut jobs after Monsanto deal",Reuters
Nov-29-18,Dow Records Highest Single Day Gain in 8 Months: 5 Picks,Zacks
Nov-29-18,Catalyst's Firdapse Receives FDA Approval for Rare Disease,Zacks
Nov-29-18,4 Big Pharma Stocks to Add to Your Portfolio in December,Zacks
Nov-29-18,"The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved",Benzinga
Nov-30-18,Novartis' Gilenya Approved in EU for Expanded Population,Zacks
Nov-30-18,Key Pharma Players With HIV Focus Ahead of World Aids Day,Zacks
Nov-30-18,"Fridays Vital Data: McDonalds, Twitter and Merck",InvestorPlace
Nov-30-18,"The Zacks Analyst Blog Highlights: Boeing, Merck, Microsoft, UnitedHealth and American Express",Zacks
Nov-30-18,Bayer (BAYRY) to Restructure Business & Reduce Headcount,Zacks
Nov-30-18,"The Zacks Analyst Blog Highlights: Merck, Mastercard, Salesforce, Diageo and State Street",Zacks
Nov-30-18,"Dow 30 Stock Roundup: BA's $383M Modification Contract, MSFT's Army Contract",Zacks
Dec-03-18,Merck (MRK) Stock Sinks As Market Gains: What You Should Know,Zacks
Dec-03-18,Shire's Takhzyro Gets European Nod for Hereditary Angioedema,Zacks
Dec-03-18,Does Keytruda's Dominance Make Merck & Co. a Buy Now?,Motley Fool
Dec-03-18,"The Zacks Analyst Blog Highlights: General Motors, Boeing, Microsoft, Merck and UnitedHealth",Zacks
Dec-03-18,Merck to Present at the Citi 2018 Global Healthcare Conference,Business Wire
Dec-04-18,Incyte (INCY) Announces Positive Data on Jakafi for GVHD,Zacks
Dec-04-18,3 Big Pharma Stocks Hitting 52-Week Highs -- Are They Buys?,Motley Fool
Dec-06-18,These 16 Top-Rated Stocks Are Showing Strength In Volatile Market,Investor's Business Daily
Dec-06-18,AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study,Zacks
Dec-06-18,"Your first trade for Thursday, December 6",CNBC
Dec-07-18,New Biotech IPO Dropped a Unicorn-Sized Value on Its First Day,Bloomberg
Dec-07-18,Mallinckrodt (MNK) to Separate Generics & Branded Businesses,Zacks
Dec-10-18,Merck (MRK) Outpaces Stock Market Gains: What You Should Know,Zacks
Dec-10-18,Mercks President of Global Human Health Adam H. Schechter to Leave Merck Frank Clyburn Named Chief Commercial Officer and Michael Nally Named Chief Marketing Officer,Business Wire
Dec-10-18,Roche's Tecentriq Gets FDA Approval for First-Line NSCLC,Zacks
Dec-10-18,PFE Stock Has Broken Its Slump and Could Challenge Former Highs,InvestorPlace
Dec-11-18,McDonald's to curb antibiotic use in its beef supply,Reuters
Dec-11-18,"Gabelli Names Clovis As Top Pick, Calls The Biotech A Likely Takeout Candidate",Benzinga
Dec-11-18,Moderna Stock Ushers In the Next Wave of Biotech,InvestorPlace
Dec-11-18,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",Benzinga
Dec-12-18,Merck and Instituto Butantan Announce Collaboration Agreement to Develop Vaccines to Protect Against Dengue Infections,Business Wire
Dec-12-18,Roche to Create Companion Diagnostic Test for Merck's Keytruda,Zacks
Dec-12-18,Pfizer's (PFE) Shares Drop on Rating Downgrade by JP Morgan,Zacks
Dec-13-18,J&J's Tremfya Beats Novartis' Cosentyx in Head-to-Head Study,Zacks
Dec-13-18,Mallinckrodt's Roxicodone Reformulation Gets CRL From FDA,Zacks
Dec-13-18,Lilly Inks Deal With AC Immune for Potential Alzheimer's Drug,Zacks
Dec-13-18,5 Dow Stocks Stand Tall Despite Index's Loss of 2018 Gains,Zacks
Dec-13-18,5 Dow Stocks Defying the Index's YTD Plunge,Zacks
Dec-14-18,Merck Slips After Announcing Acquisition of France's Antelliq Group,TheStreet.com
Dec-14-18,[$$] Merck to Buy Animal Health Tech Business for $2.37 Billion,The Wall Street Journal
Dec-14-18,"Stocks - Starbucks, Costco Slump in Premarket; Apple, Merck, Adobe Fall",Investing.com
Dec-14-18,Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?,Zacks
Dec-14-18,Merck bolsters animal health unit with $2.4 billion Antelliq purchase,Reuters
Dec-14-18,Merck bolsters animal health unit with $2.4 billion Antelliq purchase,Reuters
Dec-14-18,5 Drug/Biotech Stocks With Promise to Sustain Bull Run in 2019,Zacks
Dec-14-18,Gwynedd Mercy University nearly doubles campus with 154-acre purchase,American City Business Journals
Dec-14-18,Today's Research Reports on Trending Tickers: Pfizer and Merck & Co.,ACCESSWIRE
Dec-14-18,Merck to bolster animal health unit with $2.4 billion purchase of Antelliq,Reuters
Dec-14-18,Merck to Acquire Privately Held Antelliq Group,Business Wire
Dec-17-18,Merck (MRK) Stock Moves -1.63%: What You Should Know,Zacks
Dec-17-18,Merck to Acquire Europe's Antelliq Group for $2.4 Billion,Zacks
Dec-17-18,Incyte (INCY) Collaborates with Innovent for 3 Candidates,Zacks
Dec-17-18,Lilly (LLY) to Acquire Pain Candidate From Private Biotech,Zacks
Dec-17-18,J&J Dips 10% as Reuters Says Company Knew of Asbestos in Talc,Zacks
Dec-17-18,Better Buy: Eli Lilly and Company vs. Merck & Co.,Motley Fool
Dec-18-18,Evofem Shares Up as Birth Control Gel Succeeds in Phase III,Zacks
Dec-18-18,Merck's Keytruda Gets EU Nod as Adjuvant Therapy for Melanoma,Zacks
Dec-18-18,Lilly's Taltz Outshines Humira in Psoriatic Arthritis Study,Zacks
Dec-18-18,"J&J Okays $5B Stock Buyback Plan, Stock Remains Stressed",Zacks
Dec-19-18,AstraZeneca's ovarian cancer drug gets FDA nod as maintenance treatment,Reuters
Dec-21-18,Merck KGaA-Pfizer to end late-stage ovarian cancer treatment study,Reuters
Dec-21-18,Merck KGaA-Pfizer to terminate late-stage ovarian cancer treatment study,Reuters
Dec-21-18,"Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer",PR Newswire
Dec-21-18,Pfizer Xtandi Succeeds in Late-Stage Prostate Cancer Study,Zacks
Dec-21-18,"Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations",Zacks
Dec-21-18,Merck's sBLA for Keytruda in Lung Cancer Gets Extended Review,Zacks
Dec-21-18,"Dow 30 Stock Roundup: Nike, Walgreens Boots Earnings Impress",Zacks
Dec-21-18,5 S&P 500 Stocks Stand Tall Despite Index's Loss of 2018 Gains,Zacks
Dec-21-18,"Do Directors Own Merck & Co., Inc. (NYSE:MRK) Shares?",Simply Wall St.
Dec-24-18,"Dow Jones Falls 3,700 Points For The Month; This Blue-Chip Stock Triggers Sell Signal",Investor's Business Daily
Dec-24-18,Pfizer/Merck KGaA End Bavencio Ovarian Cancer Phase III Study,Zacks
Dec-26-18,"Sanofi: FDA Approves VAXELIS(TM), Sanofi and MSD's Pediatric Hexavalent Combination Vaccine",GlobeNewswire
Dec-26-18,"Eversept Partners Return, AUM, and Holdings",Insider Monkey
Dec-26-18,Will Big Pharma's Giant Maw Scoop Up These Small-Cap Players?,Investor's Business Daily
Dec-26-18,"Bristol-Myers Squibb Stock Is Coming Back Slow, but Thats Fine",InvestorPlace
Dec-27-18,This Is The Top Dow Stock Of 2018  And It's Not Even Close,Investor's Business Daily
Dec-27-18,Sanofi Wins FDA Nod for Pediatric Hexavalent Combo Vaccine,Zacks
Dec-27-18,Buy 5 Dow Stocks to Strengthen Your Portfolio in 2019,Zacks
Dec-27-18,"Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019",Zacks
Dec-28-18,Merck (MRK) Stock Moves -0.01%: What You Should Know,Zacks
Dec-28-18,BioXcel Surges on Fast Track Designation to Agitation Drug,Zacks
Dec-28-18,"Top Analyst Reports for Merck, Abbott & Lockheed Martin",Zacks
Dec-28-18,"Analysis: Positioning to Benefit within General Motors, RE/MAX, Genworth Financial, Merck & Co., Aerojet Rocketdyne, and Fluor  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Dec-31-18,What Happened in the Stock Market Today,Motley Fool
Dec-31-18,This Is The Top Dow Stock Of 2018  And It's Not Even Close,Investor's Business Daily
Dec-31-18,Stocks Today Brush Off The Bears; Will These 4 Lead The Dow Jones In 2019?,Investor's Business Daily
Dec-31-18,The best and worst stocks of 2018,MarketWatch
Dec-31-18,"Dow Jones Futures Jump, But Here's A Stock Market Rally Reality Check",Investor's Business Daily
Dec-31-18,"The Zacks Analyst Blog Highlights: Merck, Abbott, Lockheed Martin, United Parcel Service and Bank of New York Mellon",Zacks
Jan-02-19,Horizon Pharma (HZNP) Up 28% on Business Expansion Strategy,Zacks
Jan-02-19,Could This New Biotech IPO Could Score Big With A Cancer Vaccine?,Investor's Business Daily
Jan-02-19,Merck to Participate at the 37th Annual J.P. Morgan Healthcare Conference,Business Wire
Jan-02-19,"BriaCell Announces Switch to Novel Frozen Formulation for Lead Cancer Drug Candidate, Upcoming Attendance at Biotech Showcase 2019 and Presentation at Keystone Symposia Conference",GlobeNewswire
Jan-03-19,The Top Healthcare Stocks of 2018: Can They Continue in 2019?,Motley Fool
Jan-03-19,Bristol-Myers' (BMY) Sprycel Gets FDA Nod for Label Expansion,Zacks
Jan-03-19,P.R. Ind Tour Ed Med & Env Ctl Facs Fin Auth -- Moody's reviews Bristol-Myers Squibb for downgrade,Moody's
Jan-03-19,"UPDATE: Cocrystal Pharma to work with Merck on flu therapy, sending shares up 32% premarket",MarketWatch
Jan-03-19,Merck's Keytruda wins 5 new approvals in Japan,MarketWatch
Jan-04-19,Bristol To Become Top 5 Pharma  And Other Fallout From Celgene Takeover,Investor's Business Daily
Jan-04-19,Bristol-Myers Becomes a Cancer-Fighting Giant With Celgene Buyout,InvestorPlace
Jan-04-19,"Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate",Zacks
Jan-04-19,Bristol-Myers to Acquire Leading Biotech Celgene for $74B,Zacks
Jan-04-19,Pfizer Begins Pivotal Study on Alopecia Areata Candidate,Zacks
Jan-04-19,Today's Research Reports on Trending Tickers: Johnson & Johnson and Merck & Co.,ACCESSWIRE
Jan-04-19,"Merck Buys NASH Candidate, Keytruda Wins 5 Approvals in Japan",Zacks
Jan-07-19,Top Dow Stocks for 2018,Investopedia
Jan-07-19,Merck (MRK) Stock Sinks As Market Gains: What You Should Know,Zacks
Jan-07-19,Spiros Segalas' 5 Biggest Stock Buys of 4th Quarter,GuruFocus.com
Jan-07-19,U.S. Supreme Court could side with Merck over Fosamax lawsuits,Reuters
Jan-07-19,U.S. Supreme Court could side with Merck over Fosamax lawsuits,Reuters
Jan-07-19,Merck loses bid to revive $200 million Gilead verdict at U.S. high court,Reuters
Jan-07-19,Merck loses bid to revive $200 mln Gilead verdict at U.S. high court,Reuters
Jan-07-19,Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?,Zacks
Jan-07-19,Justice Ruth Bader Ginsburg missing oral arguments for first time in 25 years on Supreme Court,CNBC
Jan-07-19,Gilead (GILD) Collaborates With Yuhan for NASH Candidates,Zacks
Jan-07-19,"The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie",Zacks
Jan-08-19,Is It Time to Sell Celgene Stock After the Bristol-Myers Squibb Offer?,InvestorPlace
Jan-08-19,Moderna Shares Jump on Positive Cancer-Treatment Progress,TheStreet.com
Jan-08-19,Moderna's stock jumps after progress report on cancer treatments,MarketWatch
Jan-08-19,Dogs of the Dow Win in 2018: Will ETFs See Success in 2019?,Zacks
Jan-09-19,Moderna Soars After Update of Its Pipeline Programs,GuruFocus.com
Jan-09-19,"Moderna (MRNA) Announces Pipeline Progress, Shares Rise",Zacks
Jan-09-19,Novartis' Crizanlizumab Gets Breakthrough Therapy Status,Zacks
Jan-09-19,Dow Posts Longest Winning Run Since November: 5 Top Picks,Zacks
Jan-10-19,Big Pharma CEOs Indicate More M&A Deals at JP Morgan Meeting,Zacks
Jan-11-19,NASH Space in Focus in 2019 as Firms Look to Diversify,Zacks
Jan-11-19,5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019,Zacks
Jan-11-19,"Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet",Zacks
Jan-11-19,"Dow 30 Stock Roundup: Boeing Q4 Commercial Deliveries Up Y/Y, Merck Buys NASH Candidate",Zacks
Jan-11-19,3 Biotech Stocks Bubbling Away,Investopedia
Jan-11-19,4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019,Zacks
Jan-14-19,5 Reasons Why Investors Should Buy Exelixis (EXEL) in 2019,Zacks
Jan-15-19,3 of the Top Big Pharma Stocks to Buy Now,InvestorPlace
Jan-15-19,"Stock Market News For Jan 15, 2019",Zacks
Jan-15-19,"3 Big Stock Charts for Tuesday: Broadcom, Facebook and Merck",InvestorPlace
Jan-17-19,Roche's sBLA for Tecentriq-Abraxane Combo Accepted by FDA,Zacks
Jan-17-19,"Nasdaq Leads Dow Jones In Bullish Upturn; These 4 Blue Chips Are Outpacing Apple, Forming Chart Patterns",Investor's Business Daily
Jan-17-19,Bull Signal Flashing for This Healthcare Stock,Schaeffer's Investment Research
Jan-17-19,Here's Yana Barton's 2019 stock picks,CNBC Videos
Jan-17-19,"3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group",InvestorPlace
Jan-18-19,Samsung Bioepis biosimilar to Roche's Herceptin wins FDA nod,Reuters
Jan-18-19,Aerie's (AERI) Eye Care Candidate to Enter Clinical Studies,Zacks
Jan-18-19,"Dow 30 Stock Roundup: JPM &amp; AXP Earnings Disappoint, GS &amp; UNH Impress",Zacks
Jan-22-19,"J&amp;J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft",Zacks
Jan-22-19,All Signals Are Positive for Buying Abbott Laboratories,InvestorPlace
Jan-22-19,Alnylam &amp; Medison Partner to Market RNAi Products in Israel,Zacks
Jan-22-19,Merck to Hold Fourth-Quarter and Full-Year 2018 Sales and Earnings Conference Call on February 1,Business Wire
Jan-22-19,"The Zacks Analyst Blog Highlights: Bank of America, Merck, Netflix, IBM and The Bank of New York Mellon",Zacks
Jan-23-19,"Healthcare ETFs Slip After Abbot Labs Revenue Miss, Weak Outlook",ETF Trends
Jan-23-19,BMO downgrades Merck to market perform,MarketWatch
Jan-23-19,"BRIEF-Merck KGaA, Tencent Announce Collaboration On Digital Health Services In China",Reuters
Jan-24-19,[$$] Bristol-Myers Reports Higher Sales but Another Lung-Cancer Setback,The Wall Street Journal
Jan-24-19,[$$] Bristol-Myers Reports Higher Sales but Another Lung-Cancer Setback,The Wall Street Journal
Jan-24-19,Stocks waver again as chipmakers jump and drug companies dip,Associated Press
Jan-24-19,"Bristol-Myers (BMY) Beats Q4 Earnings, Withdraws Opdivo sBLA",Zacks
Jan-24-19,Healthcare ETFs in Focus Ahead of Q4 Earnings,Zacks
Jan-24-19,Sanofi's (SNY) Influenza Vaccine Gets FDA Approval for Kids,Zacks
Jan-24-19,Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors,CNW Group
Jan-24-19,Does Johnson & Johnson's Grim Outlook Spell Trouble for Big Pharma Stocks?,Motley Fool
Jan-25-19,Merck (MRK) Stock Sinks As Market Gains: What You Should Know,Zacks
Jan-25-19,"Pharma Stock Roundup: JNJ &amp; BMY's Q4 Earnings, Study Failures at LLY &amp; ABBV",Zacks
Jan-25-19,Amgen/Allergan's Rituxan Biosimilar Meets Goal in Phase III,Zacks
Jan-25-19,How to Trade Merck and Pfizer Pre-Earnings - Each Face Deteriorating Charts,TheStreet.com
Jan-25-19,"Dow 30 Stock Roundup: UTX, TRV, PG, JNJ Earnings Impress, IBM Revenues Decline Y/Y",Zacks
Jan-25-19,"3 Big Stock Charts for Friday: Merck, Broadcom and Advanced Micro Devices",InvestorPlace
Jan-25-19,Asian shares rise on optimism over China-US trade talks,Associated Press
Jan-28-19,Inovio's Early/Mid-Stage Vaccine Pipeline Exhibits Growth,Zacks
Jan-28-19,"The Zacks Analyst Blog Highlights: J&amp;J, Bristol-Myers, Lilly, AbbVie and Merck",Zacks
Jan-28-19,Merck (MRK) Q4 Earnings Coming Up: What's in the Cards?,Zacks
Jan-28-19,"3 Big Stock Charts for Monday: Pfizer, MGM Resorts and Incyte",InvestorPlace
Jan-28-19,"Heres What Merck & Co., Inc.s (NYSE:MRK) P/E Is Telling Us",Simply Wall St.
Jan-29-19,Mary Ellen Coe Elected to Merck Board of Directors,Business Wire
Jan-29-19,Merck Announces Second-Quarter 2019 Dividend,Business Wire
Jan-29-19,Why Merck (MRK) Could Beat Earnings Estimates Again,Zacks
Jan-29-19,What's next for this slow-moving Peninsula biotech IPO?,American City Business Journals
Jan-29-19,Today's Research Reports on Trending Tickers: Teva Pharmaceutical Industries and Merck & Co.,ACCESSWIRE
Jan-30-19,Roche Halts Two Late-Stage Studies on Alzheimer's Candidate,Zacks
Jan-30-19,"Merck Receives Breakthrough Therapy Designation from FDA for V114, the Companys Investigational 15-Valent Conjugate Vaccine for the Prevention of Invasive Pneumococcal Disease, in Infants, Children, and Adolescents",Business Wire
Jan-31-19,"Friday Earnings Preview: Cigna, Merck, Exxon, Honeywell All Report",TheStreet.com
Jan-31-19,Merck's Q4 Earnings Preview,Benzinga
Jan-31-19,25 Stocks to Avoid This February,Schaeffer's Investment Research
Jan-31-19,Merck's Pneumococcal Vaccine Gets Breakthrough Therapy Status,Zacks
Jan-31-19,Eli Lilly (LLY) Q4 Earnings Coming Up: What's in the Cards?,Zacks
Jan-31-19,What's in the Cards for Skyworks (SWKS) in Q1 Earnings?,Zacks
Feb-01-19,Warren Buffett's Market Indicator Rises Near 135%,GuruFocus.com
Feb-01-19,"Merck Tops Q4 Earnings, Guides for Solid 2019, as Keytruda Sales Pass $2 Billion",TheStreet.com
Feb-01-19,Dow and S&P Hold on to Slim Gains While Amazon Drags Nasdaq Into the Red,TheStreet.com
Feb-01-19,Wall Street Green on Positive Jobs Report,GuruFocus.com
Feb-01-19,Merck News: MRK Stock Moves Higher on Q4 Earnings Beat,InvestorPlace
Feb-01-19,"Merck's Keytruda tops $2 billion in quarterly sales, shares rise",Reuters
Feb-01-19,"Merck 4Q net powered by cancer treatment sales, lower taxes",Associated Press
Feb-01-19,Merck (MRK) Beats on Q4 Earnings &amp; Sales as Keytruda Shines,Zacks
Feb-01-19,Dow's 3 earnings reporters adding nearly 40 points to the rally,MarketWatch
Feb-01-19,"Merck (MRK) Tops on Q4 Earnings &amp; Sales, Stock Up",Zacks
Feb-01-19,Merck tops profit and sales estimates in latest quarter,MarketWatch
Feb-01-19,Merck's quarterly sales rise 5.4 pct on Keytruda strength,Reuters
Feb-01-19,Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results,Business Wire
Feb-01-19,"Stocks - Amazon, Cigna Sink in Premarket, Exxon, Merck, Honeywell, Symantec Rise",Investing.com
Feb-01-19,"Merck Reports In Line Q4 Results, Shares Slip",Investing.com
Feb-01-19,Top 5 Things to Know in the Market on Friday,Investing.com
Feb-04-19,"Stock Market News For Feb 4, 2019",Zacks
Feb-04-19,Why Merck (MRK) is a Great Dividend Stock Right Now,Zacks
Feb-04-19,Better Buy: Johnson & Johnson vs. Merck & Co.,Motley Fool
Feb-05-19,Merck CEO Frazier to testify at Senate drug pricing hearing,Reuters
Feb-05-19,Here's Why Codexis Gained as Much as 9.8% Today,Motley Fool
Feb-05-19,Edited Transcript of MRK earnings conference call or presentation 1-Feb-19 1:00pm GMT,Thomson Reuters StreetEvents
Feb-05-19,"Market Update: May Back to Brussels, BP Gushes Oil, Iron Spike, Pain Feels Pain",Market Exclusive
Feb-05-19,GSK pays up to $4.2 billion for Merck KGaA cancer immunotherapy,Reuters
Feb-05-19,Merck Is Named No. 1 Pharma Pick at Bank of America,TheStreet.com
Feb-05-19,Merck's Keytruda Clinches CHMP Nod for Difficult Lung Cancer,Zacks
Feb-05-19,Merck named the best pharma stock by Bank of America,CNBC
Feb-05-19,"The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results",Benzinga
Feb-06-19,"Merck & Co Inc (MRK) Chairman, President & CEO Kenneth C Frazier Sold $18. ...",GuruFocus.com
Feb-06-19,GlaxoSmithKline plc (GSK) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-06-19,Glaxo Inks Deal With Merck KGaA to Co-Develop Cancer Candidate,Zacks
Feb-06-19,Winners &amp; Losers from Trump's State of the Union Address,Zacks
Feb-07-19,Prior dengue infection may protect against Zika - study,Reuters
Feb-08-19,Incyte Down as FDA Extends Review Period of Jakafi for GVHD,Zacks
Feb-08-19,"Seattle Genetics (SGEN) Q4 Loss Widens, Revenues Top Mark",Zacks
Feb-08-19,"Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs",Zacks
Feb-08-19,"Dow 30 Stock Roundup: Disney Earnings Impress, Pfizer's Cancer Drug Gets CHMP Nod",Zacks
Feb-11-19,Exclusive: Kilroy's high-profile biotech project ready to go vertical,American City Business Journals
Feb-11-19,Merck Highlights Breadth of Immuno-Oncology Research Program in Genitourinary Cancers at ASCO GU,Business Wire
Feb-11-19,Jeff Auxier's Winter 2018 Market Commentary,GuruFocus.com
Feb-11-19,"ImmunoGen (IMGN) Beats on Earnings &amp; Sales in Q4, Shares Up",Zacks
Feb-12-19,Aduro Initiates Dosing in Phase I Melanoma Study on ADU-S100,Zacks
Feb-12-19,Bristol-Myers' Sprycel Gets European Nod for Label Expansion,Zacks
Feb-12-19,"Dash for NASH trips up Gilead, but 'fatty liver disease' remains biotech target",American City Business Journals
Feb-12-19,Seattle Genetics' Adcetris Gets EC Nod for Label Expansion,Zacks
Feb-12-19,Jeff Auxier Comments on Merck & Co.,GuruFocus.com
Feb-12-19,Pfizer sBLA for Kidney Cancer Drug Combo Gets Priority Review,Zacks
Feb-12-19,"Stock Market News For Feb 12, 2019",Zacks
Feb-12-19,Positive Data for Merck's Keytruda Opens Growth Avenue,Morningstar
Feb-12-19,Merck's Keytruda Gets FDA Priority Review for Head/Neck Cancer,Zacks
Feb-13-19,"Top Research Reports for ExxonMobil, Merck & Danaher",Zacks
Feb-14-19,"Incyte (INCY) Q4 Earnings Miss Estimates, Revenues Beat",Zacks
Feb-14-19,"The Zacks Analyst Blog Highlights: ExxonMobil, Merck, Danaher, Novartis and Expedia",Zacks
Feb-14-19,Merck to further study Keytruda in prostate cancer after early success,Reuters
Feb-14-19,"AstraZeneca's (AZN) Q4 Earnings Beat, New Drugs Drive Sales",Zacks
Feb-14-19,[$$] Cyber Daily: Bumpy Road to NotPetya Insurance Payouts; Espionage in Iran,The Wall Street Journal
Feb-14-19,"Merck Increases Focus on Advanced Prostate Cancer, Expanding Immuno-Oncology Program with Three New Phase 3 Trials",Business Wire
Feb-14-19,"AstraZeneca Surges as Oncology Sales Drive Q4 Earnings Beat, Solid 2019 Outlook",TheStreet.com
Feb-15-19,"Merck Sharp & Dohme Corp. -- Moody's announces completion of a periodic review of ratings of Merck & Co., Inc.",Moody's
Feb-19-19,"Merck & Co Inc (MRK) Chairman, President & CEO Kenneth C Frazier Sold $10. ...",GuruFocus.com
Feb-19-19,Merck's Keytruda fails late-stage study in liver cancer patients,Reuters
Feb-19-19,Merck's Keytruda fails late-stage study in liver cancer patients,Reuters
Feb-19-19,Merck stock falls in late trading on cancer study,MarketWatch
Feb-20-19,Edited Transcript of MRK earnings conference call or presentation 1-Feb-19 1:00pm GMT,Thomson Reuters StreetEvents
Feb-20-19,Why Merck (MRK) is a Top Dividend Stock for Your Portfolio,Zacks
Feb-20-19,Merck's Keytruda Fails to Meet Endpoint in Liver Cancer Study,Zacks
Feb-20-19,"Intercept Reports Positive Top-Line Data for NASH, Shares Up",Zacks
Feb-20-19,Merck expands Mass. reach with Torque cancer collaboration,American City Business Journals
Feb-20-19,Merck Shares Drop After Keytruda Treatment Fails Late-Stage Liver Cancer Trial,TheStreet.com
Feb-20-19,"The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering",Benzinga
Feb-20-19,"New Research: Key Drivers of Growth for DISH Network, Avon Products, Merck & Co., Laredo Petroleum, Health Insurance Innovations, and Bruker  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Feb-21-19,ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Immune Design Corp.,PR Newswire
Feb-21-19,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Immune Design Corp. to Merck & Co., Inc. for $5.85 Per Share is Fair to Shareholders",GlobeNewswire
Feb-21-19,Merck To Buy Immune Design For $300M,Benzinga
Feb-21-19,Merck Gets Priority Review for Keytruda in Third-Line SCLC,Zacks
Feb-21-19,Immune Design (IMDZ) Alert: Johnson Fistel Investigates Proposed Sale of Immune Design Corp.; Are Immune Design Shareholders Getting a Fair Deal?,PR Newswire
Feb-21-19,Merck to buy immunotherapy developer Immune Design for $300 mln,Reuters
Feb-21-19,Merck to Acquire Immune Design,Business Wire
Feb-22-19,"Merck & Co Inc (MRK) Chairman, President & CEO Kenneth C Frazier Sold $7.7 million of Shares",GuruFocus.com
Feb-22-19,Merck to Buy Immunotherapy Developer Immune Design for $300M,Zacks
Feb-22-19,What's in the Cards for Perrigo (PRGO) This Earnings Season?,Zacks
Feb-22-19,"Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates",Zacks
Feb-22-19,"Dow 30 Stock Roundup: WMT Earnings Beat, MRK's Keytruda sBLA Gets Priority Review",Zacks
Feb-25-19,Technician says it's time to fade the biotech rally,CNBC Videos
Feb-25-19,Drugmakers CEOs set to get grilled at Senate hearing on rising drug prices,MarketWatch
Feb-25-19,"The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft",Zacks
Feb-25-19,"The Zacks Analyst Blog Highlights: Merck, Design, Roche and AbbVie",Zacks
Feb-25-19,"Pharma M&A Wave: Spark Therapeutics, Clementia Pharma Among The Rare Disease Biotechs Acquired",Benzinga
Feb-26-19,Lawmakers grill top pharma execs over high drug costs,CNBC Videos
Feb-26-19,Drugmakers CEOs clash with senators in hearing on drug price hikes,MarketWatch
Feb-26-19,5 Stock Charts Ripe for a Breakout,InvestorPlace
Feb-26-19,The Latest: Senators urge pharma CEOs to rein in lobbyists,Associated Press
Feb-26-19,Senators say will support Judiciary panel if it looks into drug patents,Reuters
Feb-26-19,Pharma execs offer Senate ideas to lower drug costs  except actually cutting prices,CNBC
Feb-26-19,Drugmakers CEOs set to get grilled at Senate hearing on rising drug prices,MarketWatch
Feb-27-19,[$$] Germany's Merck Makes $5.24 Billion Offer for Versum Materials,The Wall Street Journal
Feb-27-19,Germany's Merck makes $5.9 bln counterbid for Versum,Reuters
Feb-27-19,Here's Why Versum Materials Rose as Much as 18.3% Today,Motley Fool
Feb-27-19,Versum Sticks With Merger Plan as German Merck Barges In,Bloomberg
Feb-27-19,Germany's Merck makes $5.9 billion counterbid for Versum,Reuters
Feb-27-19,Merck KGaA offers to buy Versum Materials in all-cash deal valued at $5.9 billion,MarketWatch
Feb-27-19,AstraZeneca/Merck's Lynparza Meets Endpoint in POLO Study,Zacks
Feb-28-19,"Perrigo (PRGO) Q4 Earnings Miss, Sales Beat, Stock Down",Zacks
Feb-28-19,"Factors of Influence in 2019, Key Indicators and Opportunity within Franklin Resources, Heartland Express, Ameriprise Financial, Merck & Co., NGL Energy Partners LP, and ResMed  New Research Emphasizes Economic Growth",GlobeNewswire
Mar-01-19,"Endo (ENDP) Q4 Earnings &amp; Revenues Beat Estimates, Shares Up",Zacks
Mar-01-19,Versum Materials rejects Merck KGaA's unsolicited offer,Reuters
Mar-01-19,"Intercept (ICPT) Up on Q4 Revenue Beat, NASH Study in Focus",Zacks
Mar-01-19,Versum Materials rejects Merck KGaA's unsolicited offer,Reuters
Mar-01-19,Esperion (ESPR) Reports Wider-Than-Expected Loss in Q4,Zacks
Mar-05-19,Merck Prices $5.0 Billion Debt Offering,Business Wire
Mar-05-19,"Merck & Co., Inc. -- Moody's assigns A1 rating to Merck's notes; stable outlook",Moody's
Mar-05-19,Merck KGaA urges Versum shareholders to support takeover bid,Reuters
Mar-05-19,Merck Gets CHMP Nod for Six-Week Dosing Option of Keytruda,Zacks
Mar-05-19,Merck Begins Tender Offer to Acquire Immune Design,Business Wire
Mar-05-19,Merck KGaA urges Versum shareholders to pipe up for rival bid,Reuters
Mar-06-19,Roche's (RHHBY) sNDA for Flu Candidate Accepted by the FDA,Zacks
Mar-07-19,Merck KGaA encouraged by market reaction to Versum swoop,Reuters
Mar-08-19,"Pharma Stock Roundup: FDA OK's J&amp;J Antidepressant, CHMP Recommends Several Drugs",Zacks
Mar-08-19,"Versum, Entegris see extra merger benefits, Merck hires Goldman",Reuters
Mar-08-19,Roche's (RHHBY) Tecentriq Gets EC Nod for First-Line NSCLC,Zacks
Mar-08-19,Merck KGaA mandates Goldman as additional advisor for Versum deal,Reuters
Mar-08-19,[$$] Kings and Wellcome sign US deal to develop painkillers,Financial Times
Mar-11-19,Seres teams up with AstraZeneca to explore microbiome benefits in cancer treatment,American City Business Journals
Mar-11-19,"The Zacks Analyst Blog Highlights: J&amp;J, Lilly, Pfizer, AstraZeneca and Merck's",Zacks
Mar-12-19,BioNtech hires banks for IPO worth up to $800 million - sources,Reuters
Mar-12-19,Biontech stock offering could be worth as much as $800 million-sources,Reuters
Mar-12-19,Merck KGaA calls on Versum investors to vote down Entegris merger,Reuters
Mar-12-19,Pfizer's (PFE) Kidney Cancer Drug Combo Gets EMA's Validation,Zacks
Mar-12-19,Why Merck (MRK) is a Great Dividend Stock Right Now,Zacks
Mar-13-19,Merck (MRK) Gains But Lags Market: What You Should Know,Zacks
Mar-13-19,Lilly's Cyramza Successful in Phase III First-Line NSCLC Study,Zacks
Mar-14-19,"Thursdays Vital Data: Aurora Cannabis, Roku and Merck",InvestorPlace
Mar-15-19,Merck's Keytruda Gets EU Approval for Difficult Lung Cancer,Zacks
Mar-15-19,"Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&amp;J, AGN &amp; Others",Zacks
Mar-18-19,"Top Research Reports for Merck, Adobe & Broadcom",Zacks
Mar-18-19,"IMMUNE DESIGN CORP. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger",GlobeNewswire
Mar-18-19,"The Zacks Analyst Blog Highlights: Pfizer, Roche, Merck, Allergan and J&amp;J",Zacks
Mar-18-19,AstraZeneca Up This Year on New Drugs &amp; Pipeline Progress,Zacks
Mar-18-19,New Treatment Option Now Available in Canada for Newly Diagnosed Patients with Advanced Lung Cancer,CNW Group
Mar-19-19,"[$$] If This Is Failure, Show Me Success",The Wall Street Journal
Mar-19-19,Merck (MRK) Gains As Market Dips: What You Should Know,Zacks
Mar-19-19,"Post-GSK purchase, Tesaro readies for cancer clash with Merck",American City Business Journals
Mar-19-19,"The Zacks Analyst Blog Highlights: Merck, Adobe, Broadcom, AstraZeneca and Ross Stores",Zacks
Mar-19-19,Roche's Tecentriq Gets FDA Approval for Difficult Lung Cancer,Zacks
Mar-19-19,Why You Should Buy ABBV Stock for Income and Value,InvestorPlace
Mar-20-19,"BriaCell Announces $2,000,000 Non-Brokered Private Placement Offering",GlobeNewswire
Mar-20-19,Pfizer/Merck KGaA End Bavencio+Talzenna Ovarian Cancer Study,Zacks
Mar-20-19,Glaxo Presents Encouraging Data on Endometrial Cancer Drug,Zacks
Mar-20-19,Industry Consortium Launched to Qualify Biomarkers for Schizophrenia Drug Development,Business Wire
Mar-20-19,"Merck and NGM Bio Announce Extension of Broad, Multi-Year Strategic Collaboration to 2022",Business Wire
Mar-21-19,Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market,Zacks
Mar-21-19,Bristol-Myers' Celgene Buyout Still Uncertain Amid Opposition,Zacks
Mar-25-19,"Were Hedge Funds Right About Merck & Co., Inc. (MRK)?",Insider Monkey
Mar-25-19,Merck (MRK) Gains As Market Dips: What You Should Know,Zacks
Mar-25-19,5 Dow Jones Stocks for the End of Muellers Investigation,InvestorPlace
Mar-25-19,S&P 500 Q4 2018 Buybacks Set 4th Consecutive Quarterly Record at $223 Billion; 2018 Sets Record $806 Billion,PR Newswire
Mar-25-19,"Report: Exploring Fundamental Drivers Behind ON Semiconductor, Pilgrim's Pride, Merck & Co., Healthcare Services Group, Genomic Health, and Spectrum Pharmaceuticals  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Mar-26-19,Merck KGaA goes hostile in $5.9 billion Versum takeover battle,Reuters
Mar-26-19,Merck KGaA goes hostile in $5.9 billion Versum takeover battle,Reuters
Mar-26-19,ETFs to Ride on Share Buyback Craze,Zacks
Mar-26-19,Merck KGaA goes hostile in $5.9 billion Versum takeover battle,Reuters
Mar-26-19,Merck Stock Set to Test 18-Year Resistance,Investopedia
Mar-26-19,"Six months after IPO filing, Peninsula biotech's offering is on again  and upsized",American City Business Journals
Mar-26-19,Merck KGaA makes takeover offer for Versum to shareholders,Reuters
Mar-28-19,One Key Strategy to Build Your Ultimate Retirement Portfolio,InvestorPlace
Mar-29-19,"Versum opens books, begins to warm to rival suitor Merck KGaA",Reuters
Mar-29-19,"Seattle Genetics, Astellas Report Positive Cancer Study Data",Zacks
Mar-29-19,"Merck KGaA welcomes Versum's decision to talk, keeps tender going",Reuters
Mar-29-19,"Merck KGaA welcomes Versum's decision to talk, keeps tender going",Reuters
Mar-29-19,UPDATE 1-Versum urges shareholders to reject Merck KGaA hostile bid,Reuters
Mar-29-19,Versum urges shareholders to reject Merck KGaA hostile bid,Reuters
Apr-01-19,BriaCell Announces Closing of Upsized & Oversubscribed Non-Brokered Private Placement of $2.97 Million,GlobeNewswire
Apr-01-19,Merck Completes Acquisition of Antelliq Corporation to Become Leader in Emerging Digital Technology for Livestock and Companion Animals,Business Wire
Apr-01-19,AstraZeneca's Selumetinib Gets Breakthrough Therapy Status,Zacks
Apr-01-19,"Biotech Winners, Losers In Q1",Benzinga
Apr-01-19,Advaxis Shares Surge After Positive Clinical Trial Updates,Benzinga
Apr-01-19,Biotech News: Why Advaxis Stock Is Soaring Today,InvestorPlace
Apr-01-19,AstraZeneca's Rare Pediatric Genetic Disorder Drug Granted Breakthrough Therapy Designation,Benzinga
Apr-01-19,Bristol-Myers' (BMY) Acquisition of Celgene Looks Certain,Zacks
Apr-01-19,Merck Shares Gain After Lung Cancer Drug Keytruda Approved for Sale In China,TheStreet.com
Apr-01-19,3 Big Pharma Stocks to Add to Your Portfolio This April,Zacks
Apr-02-19,BriaCell Announces Clinical Trial Collaboration Agreement with Incyte,GlobeNewswire
Apr-02-19,12 Dividend Stocks That Hedge Funds Love,Kiplinger
Apr-02-19,Merck's Keytruda Gets Nod for First-Line Lung Cancer in China,Zacks
Apr-02-19,Advaxis Up on Positive Early-Stage Immunotherapy Study Data,Zacks
Apr-02-19,Merck Completes Tender Offer to Acquire Immune Design,Business Wire
Apr-02-19,Merck to Hold First-Quarter 2019 Sales and Earnings Conference Call on April 30,Business Wire
Apr-05-19,"Pharma Stock Roundup: NVS Inks Immunology Deal, PFE, TEVA Get Drug Approvals in EU",Zacks
Apr-05-19,Myriad Genetics Expands CDx Tie Up With AstraZeneca &amp; Merck,Zacks
Apr-05-19,Diagnosis of Economy Ahead of World Health Day: 6 Picks,Zacks
Apr-05-19,"Dow 30 Stock Roundup: WBA Q2 Earnings Disappoint, PFE Lung Cancer Drug Gets EU Approval",Zacks
Apr-08-19,Merck (MRK) Stock Sinks As Market Gains: What You Should Know,Zacks
Apr-08-19,Merck KGaA wins Versum's support for sweetened $6.5 billion offer,Reuters
Apr-08-19,Aeglea (AGLE) Reports New Positive Data for Pegzilarginase,Zacks
Apr-08-19,J&amp;J Stock on an Uptrend This Year So Far: More Room to Run?,Zacks
Apr-08-19,"The Zacks Analyst Blog Highlights: Pfizer, Teva, Novartis, Merck and AstraZeneca",Zacks
Apr-08-19,Merck wins takeover battle for Versum with $6.4bn offer,Financial Times
Apr-08-19,Merck KGaA raises offer for Versum Materials to $53 per share,Reuters
Apr-08-19,Merck KGaA raises offer for Versum Materials to $53 per share,Reuters
Apr-09-19,10 Dow Jones Stocks Holding the Blue Chip Index Back,InvestorPlace
Apr-09-19,Heres Where You Buy 3M Stock for Capital Gains,InvestorPlace
Apr-10-19,Here's what to expect from the stock market next month,Investopedia
Apr-10-19,Amgen's (AMGN) Osteoporosis Drug Evenity Gets FDA Approval,Zacks
Apr-10-19,AstraZeneca/Merck's Lynparza Wins EU Nod for Breast Cancer,Zacks
Apr-10-19,"Merck & Co., Inc. (NYSE:MRK) Is An Attractive Dividend Stock, Here's Why",Simply Wall St.
Apr-12-19,Merck's Keytruda Gets FDA Nod for Expanded Lung Cancer Group,Zacks
Apr-12-19,Merck KGaA Signs Versum Buyout Deal; Entegris Receives Termination Payment,Benzinga
Apr-12-19,"Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal",Zacks
Apr-12-19,Merck KGaA clinches $6.5 billion Versum takeover in bet on electrochemicals,Reuters
Apr-12-19,5 things to know about Hookipa Pharma ahead of its IPO,MarketWatch
Apr-12-19,Merck KGaA to buy Versum in all-cash deal valued at 5.8 billion euros,MarketWatch
Apr-12-19,"The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug",Benzinga
Apr-15-19,Merck (MRK) Dips More Than Broader Markets: What You Should Know,Zacks
Apr-15-19,Bristol-Myers' Shareholders Vote for Celgene Acquisition,Zacks
Apr-15-19,J&amp;J's Erdafitinib Gets FDA Approval for Urothelial Cancer,Zacks
Apr-16-19,"J&amp;J (JNJ) Beats on Q1 Earnings, Ups 2019 Sales Growth View",Zacks
Apr-16-19,Why Merck (MRK) is a Top Dividend Stock for Your Portfolio,Zacks
Apr-16-19,"The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives",Benzinga
Apr-16-19,Merck Financial Services GmbH -- Moody's affirms Merck KGaA's ratings; stable outlook,Moody's
Apr-17-19,EMD FINANCE LLC -- Moody's affirms Merck KGaA's ratings; stable outlook,Moody's
Apr-17-19,Bristol-Myers Squibb Company -- Moody's assigns A2 to Bristol-Myers's exchange notes; under review for downgrade,Moody's
Apr-17-19,3 Charts That Suggest Healthcare Stocks Are Headed Lower,Investopedia
Apr-17-19,You can capture a dividend above 5% and still enjoy stock-market growth,MarketWatch
Apr-18-19,Keeley Funds Comments on Versum Materials,GuruFocus.com
Apr-18-19,Health-care drama has now spread to biopharma stocks,MarketWatch
Apr-18-19,"Clovis Focuses on Rubraca Label Expansion, Competition Stiff",Zacks
Apr-18-19,Can Q1 Earnings Lift Healthcare ETFs Higher?,Zacks
Apr-18-19,Here Are the Key Takeaways From J&amp;J's Q1 Earnings Report,Zacks
Apr-18-19,Novo Nordisk's (NVO) Share Price Rises YTD on Strong Pipeline,Zacks
Apr-18-19,You can capture a dividend above 5% and still enjoy stock-market growth,MarketWatch
Apr-22-19,Merck's Keytruda wins FDA approval as combination therapy for kidney cancer,Reuters
Apr-22-19,Merck's Keytruda wins FDA approval as combination therapy for kidney cancer,Reuters
